Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-26

Clinical Trial Update: Belatacept Therapy for the Failing Renal Allograft [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on belatacept therapy for failing renal allograft has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • belatacept (belatacept)

Snippet

Sponsor: Andrew B Adams | Conditions: Failing Renal Allograft | Phase 3 | Status: COMPLETED | Results posted: 2021-01-26